Brazilian policy for the distribution and production of antiretroviral drugs: a privilege or a right?;A política brasileira de distribuição e produção de medicamentos anti-retrovirais: privilégio ou um direito?

Cadernos de saúde pública / Ministério da Saúde, Fundação Oswaldo Cruz, Escola Nacional de Saúde Pública

Volumn 18, Issue 1, 2002, Pages 213-219

  Galvao, Jane ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; DRUG INDUSTRY; DRUG LEGISLATION; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HUMAN; LEGAL ASPECT; PATENT;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-HIV AGENTS; DRUG INDUSTRY; HEALTH POLICY; HEALTH SERVICES ACCESSIBILITY; HUMANS; LEGISLATION, DRUG; PATENTS;

MLCS; MLOWN;

EID: 1342293437     PISSN: 0102311X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0102-311x2002000100022     Document Type: Article

References (0)